Scientists have developed a new model which could help those with the acquired brain injury seen in neurodegenerative diseases.
Researchers of the University of California, San Francisco, used worms and mice to explain why the brain injury occurs in the frontotemporal lobe, which has implications for the treatment of conditions such as Alzheimer's and Parkinson's disease as well as cancers.
Aimee Kao, researcher, said: "If our findings hold up they may suggest a new way to think about how to treat neurodegenerative diseases."
Meanwhile, a drug has been found to halt the progression of Parkinson's disease in mice and is now being tested on humans, scientists have said.
Research published online in the Journal of Biological Chemistry found that phenylbutyrate effectively switches on a specific gene which is then able to protect the dopamine neurones in people with Parkinson's disease.
Senior author Curt Freed of the University of Colorado School of Medicine said the findings could mean that Parkinson's patients will one day be able to take a pill which will halt the progression of the condition.
